Skip to main content
Zaker I. Schwabkey
( out of 38 reviews )

Zaker I. Schwabkey, MD

Languages spoken: Arabic, English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
2000 Circle of Hope
Salt Lake City , UT 84112

Dr. Zaker I. Schwabkey is a physician and Assistant Professor of Medicine in the Division of Hematology and Hematologic Malignancies at the University of Utah and a clinical investigator at the Huntsman Cancer Institute. He specializes in the treatment of myeloid malignancies, with a particular focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and myeloproliferative neoplasms (MPN).

His research program focuses on the development of early-phase clinical trials for patients with myeloid malignancies. His work integrates translational science with investigator-initiated studies and collaborations with industry partners to identify novel therapeutic targets and improve treatment outcomes.

At the national level, he is actively involved in leukemia research collaborations and serves as the Huntsman Cancer Institute representative to the Acute Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).

He completed a postdoctoral research fellowship in genomic and cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, Texas and his internal medicine residency at Albany Medical College in Albany, New York, followed by fellowship training in hematology and medical oncology at Moffitt Cancer Center in Tampa, Florida, where he served as chief fellow.

Board Certification

American Board of Internal Medicine (Sub: Hematology)
National Board of Physicians and Surgeons
American Board of Internal Medicine (Sub: Medical Oncology)
American Board of Internal Medicine (Internal Medicine)

Patient Rating

Patients consistently praise Dr. Schwabkey for clear, thorough explanations, strong hematology knowledge, and a warm, empathetic manner that helps them feel heard and respected. Many comments highlight that he takes time to answer questions in understandable language, includes patients in decisions, and ensures staff follow-up. A small number of reviewers wanted more guidance on which questions to ask and clearer expectations about timing of treatment, but overall feedback is highly positive.

Generated via Patient Reviews

4.8 /5
( out of 38 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


May 21, 2026
HUNTSMAN CANCER CENTER

I've had a good experience with Dr Schwabkey over the past 5 months.

Mar 31, 2026
HUNTSMAN CANCER CENTER

Dr. Schwabkey was very engaging regarding my health and how to proceed with the treatment. I am very grateful for that.

Mar 29, 2026
HUNTSMAN CANCER CENTER

professional-forthright but with a human and empathetic touch-as good as it gets

Mar 07, 2026
HUNTSMAN CANCER CENTER

Excellent Doctor, very thorough and knowledgeable.

Feb 23, 2026
HUNTSMAN CANCER CENTER

A provider who listens, explains and cares about his patients AND takes the time to make sure we understand the directions for medications

Feb 16, 2026
HUNTSMAN CANCER CENTER

Top shelf and I was impressed with him and will talk very highly of him

Feb 15, 2026
HUNTSMAN CANCER CENTER

No one comes to Huntsman just for fun. I wanted to get treated with honesty and respect for my concerns and feelings. That is exactly what I received.

Jan 26, 2026
HUNTSMAN CANCER CENTER

Dr Schwabkey is very knowledgeable and kind. I feel very confident with him on my health care journey!

Jan 26, 2026
HUNTSMAN CANCER CENTER

Great staff

Jan 20, 2026
HUNTSMAN CANCER CENTER

Dr. Schwabkey is highly educated and knowledgeable in hematology. I am relatively informed due to experience in medical laboratory science, but learned a great deal during our visit. He was able to provide explanations and descriptions that could be easily understood by any lay person. He is personable and exudes a warmth and friendly demeanor. He connects with patients and shows compassion. He is a shining example of an ideal physician.

Nov 10, 2025
HUNTSMAN CANCER CENTER

He was good .

Nov 10, 2025
HUNTSMAN CANCER CENTER

We love Dr Schwabkey, he is so caring and helps my mother understand every aspect of her care. She leaves his office always stating how much she appreciates how he answers her questions with words she understands and explains everything so well. She is 94 years old so its important that she feels heard and she still has a say in her care. Thank you so much for treating her with such kindness and respect it makes her feel safe when in your care.

Nov 01, 2025
HUNTSMAN CANCER CENTER

Very knowledgeable and explained things clearly

Oct 12, 2025
HUNTSMAN CANCER CENTER

very competent, very professional, went over and explained what I needed to know

Oct 04, 2025
HUNTSMAN CANCER CENTER

Dr. Schwabkey is very good. He is quite professional, a good listener and includes the patient in course of treatment. My wife and I like him a lot and are happy with the care he is providing.

Sep 29, 2025
HUNTSMAN CANCER CENTER

He was genuinely happy about the results of the medication working as it should.

Aug 15, 2025
HUNTSMAN CANCER CENTER

This was my first visit with Dr Schwabkey and I was so impressed with the care and concern he had for me as a new patient. He was so thorough and explained things in a way I could understand. He let me ask questions and answered them so I could understand fully about my diagnosis.

Jul 05, 2025
HUNTSMAN CANCER CENTER

Dr. Schwabkey is an excellent doctor.

Jun 27, 2025
HUNTSMAN CANCER CENTER

He was proactive regarding my care and took steps to help me feel better.

Jun 09, 2025
HUNTSMAN CANCER CENTER

Knowledgable, considerate,

Feb 09, 2025
HUNTSMAN CANCER CENTER

Dr. Schwabkey came to us shook hands personally and told us about the test results in understandable words and phrases. He asked us if we had any questions and answered them to our satisfaction. After he left his nurse assistant answered more questions.In the meantime we had a couple more for the Dr. and he came back in and answered our questions. It was a very good experiance all around. Thanks

Jan 06, 2025
HUNTSMAN CANCER CENTER

Easy talk to and explains things so I can understand

Jan 05, 2025
HUNTSMAN CANCER CENTER

Very caring and put me at ease by taking his time to get to know me.

Dec 12, 2024
HUNTSMAN CANCER CENTER

I think I should have been guided as to what questions I should have asked the doctor when he gave me his diagnosis. I was surprised when the doctor told me that I should just wait for my hemoglobin to drop further before he could give me treatment. [TRANSLATED]

Nov 19, 2024
HUNTSMAN CANCER CENTER

Dr. Schwabkey was very thorough and patient, and took time to explain things in a way I could understand. He was also very thorough in answering all questions that I had.

Nov 15, 2024
HUNTSMAN CANCER CENTER

Dr. Schwabkey was amazing.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Dr. Zaker I. Schwabkey is a physician and Assistant Professor of Medicine in the Division of Hematology and Hematologic Malignancies at the University of Utah and a clinical investigator at the Huntsman Cancer Institute. He specializes in the treatment of myeloid malignancies, with a particular focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and myeloproliferative neoplasms (MPN).

His research program focuses on the development of early-phase clinical trials for patients with myeloid malignancies. His work integrates translational science with investigator-initiated studies and collaborations with industry partners to identify novel therapeutic targets and improve treatment outcomes.

At the national level, he is actively involved in leukemia research collaborations and serves as the Huntsman Cancer Institute representative to the Acute Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).

He completed a postdoctoral research fellowship in genomic and cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, Texas and his internal medicine residency at Albany Medical College in Albany, New York, followed by fellowship training in hematology and medical oncology at Moffitt Cancer Center in Tampa, Florida, where he served as chief fellow.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Hematology & Hematologic Malignancies
Board Certification
American Board of Internal Medicine (Sub: Hematology)
National Board of Physicians and Surgeons
American Board of Internal Medicine (Sub: Medical Oncology)
American Board of Internal Medicine (Internal Medicine)

Education history

Professional Medical Medicine - Jordan University of Science & Technology School of Medicine M.D.
Postdoctoral Fellowship Cancer Medicine - University of Texas MD Anderson Cancer Center Postdoctoral Research Fellow
Residency Internal Medicine - Albany Medical College Resident
Fellowship Hematology/Oncology - Moffitt Cancer Center Fellow
Fellowship Hematology/Oncology - Moffitt Cancer Center Chief Fellow

Selected Publications

Journal Article

  1. Rami S Komrokji, MBBS, Luca Lanino, MD, Somedeb Ball, MD, Jan P Bewersdorf, MD, Monia Marchetti, MD, Giulia Maggioni, MD, Erica Travaglino, BSc, Najla H Al Ali, MSc, Pierre Fenaux, MD, Uwe Platzbecker, MD, Valeria Santini, MD, Maria Diez-Campelo, MD, Avani Singh, MD, Akriti Gupta Jain, MD, Luis E Aguirre, MD, Sarah M Tinsley-Vance, PhD, Zaker I Schwabkey, MD, Onyee Chan, MD, Zhouer Xie, MD, Andrew M Brunner, MD, Andrew T Kuykendall, MD, Prof John M Bennett, MD, Rena Buckstein, MD, Rafael Bejar, MD, Hetty E Carraway, MD, Amy E DeZern, MD, Elizabeth A Griffiths, MD, Stephanie Halene, MD, Robert P Hasserjian, MD, Jeffrey Lancet, MD, Alan F List, MD, Sanam Loghavi, MD, Olatoyosi Odenike, MD, Eric Padron, MD, Mrinal M Patnaik, MBBS, Gail J Roboz, MD, Maximilian Stahl, MD, Prof Mikkael A Sekeres, MD, David P Steensma, MD, Michael R Savona, MD, Justin Taylor, MD, Mina L Xu, MD, Kendra Sweet, MD, David A Sallman, MD, Stephen D Nimer, MD, Christopher S Hourigan, DM, Andrew H Wei, MBBS, Elisabetta Sauta, PhD, Saverio D'Amico, MSc, Gianluca Curriculum Vitae Zaker I. Schwabkey, MD 3 Asti, MSc, Gastone Castellani, PhD, Mattia Delleani, MSc, Alessia Campagna, MD, Uma M Borate, MD, Guillermo Sanz, MD, Fabio Efficace, PhD, Steven D Gore, MD, Tae Kon Kim, MD, Navel Daver, MD, Guillermo Garcia-Manero, MD, Maria Rozman, MD, Alberto Orfao, MD, Sa A Wang, MD, M Kathryn Foucar, MD, Ulrich Germing, MD, Torsten Haferlach, MD, Phillip Scheinberg, MD, Yasushi Miyazaki, MD, Marcelo Iastrebner, MD, Austin Kulasekararaj, MD, Thomas Cluzeau, MD, Shahram Kordasti, MD, Arjan A van de Loosdrecht, MD, Lionel Ades, MD, Amer M Zeidan, MD, Matteo G Della Porta, MD (2024). Data-driven, harmonized classification system for myelodysplastic syndromes: a consensus study from the International Consortium for Myelodysplastic Syndromes (icMDS), The Lancet Haematology, [2024]. Lancet Haematol, 11(11), e862-e872.
  2. Schwabkey ZI, Wiesnoski DH, Chang CC, Tsai WB, Pham D, Ahmed SS, Hayase T, Ortega Turrubiates MR, El-Himri RK, Sanchez CA, Hayase E, Frenk Oquendo AC, Miyama T, Halsey TM, Heckel BE, Brown AN, Jin Y, Raybaud M, Prasad R, Flores I, McDaniel L, Chapa V, Lorenzi PL, Warmoes MO, Tan L, Swennes AG, Fowler S, Conner M, McHugh K, Graf T, Jensen VB, Peterson CB, Do KA, Zhang L, Shi Y, Wang Y, Galloway-Pena JR, Okhuysen PC, Daniel-MacDougall CR, Shono Y, Burgos da Silva M, Peled JU, van den Brink MRM, Ajami N, Wargo JA, Reddy P, Valdivia RH, Davey L, Rondon G, Srour SA, Mehta RS, Alousi AM, Shpall EJ, Champlin RE, Shelburne SA, Molldrem JJ, Jamal MA, Karmouch JL, Jenq RR (2022). Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci Transl Med, 14(671), eabo3445.
  3. Schwabkey ZI, Al Ali N, Chan O, Sallman DA, Padron E, Kuykendall AT, Talati C, Sweet K, Lancet JE, Komrokji RS (2021). Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype. Clin Lymphoma Myeloma Leuk, 21(1), e52-e56.
  4. Schwabkey Z, Al Ali N, Sallman D, Kuykendall A, Talati C, Sweet K, Lancet J, Padron E, Komrokji R (2021). Impact of obesity on survival of patients with myelodysplastic syndromes. Hematology, 26(1), 393-397.
  5. Schwabkey ZI, Sheehan FC, Bellomo C, Raval M (2020). Congenital dysfibrinogenaemia presented with preterm premature rupture of the membranes and vaginal bleeding. BMJ Case Rep, 13(9).

Review

  1. Schwabkey ZI, Jenq RR (2020). Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. [Review]. Annu Rev Med, 71, 137-148.
  2. Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR (2017). Clinical Evidence for the Microbiome in Inflammatory Diseases. [Review]. Front Immunol, 8, 400.

Book Chapter

  1. Schwabkey Z, Deutsch Y, Sallman D (2024). Aplastic Anemia. In Non-malignant hematologic disorders (1st Edition).
  2. Schwabkey Z, Abushukair H, Kareem SS, Benson K (2024). Recombinant Human Plasma Proteins in Clinical Practice. In Non-malignant hematologic disorders (1st Edition).
  3. Schwabkey Z, Pinilla J (2024). Chronic Myelogenous Leukemia. In Handbook of Hematologic Malignancies (3rd Edition).
  4. Schwabkey Z, Kuykendall A (2024). Polycythema Vera. In Handbook of Hematologic Malignancies (3rd Edition).
  5. Schwabkey Z, Kuyekndall A (2024). Essential Thrombocythemia. In Handbook of Hematologic Malignancies (3rd Edition).